Source comparison
TB-500 Reddit Reviews Community: Comparison Across Protocols
Loading Phase (4 weeks) 2–2.5mg per injection Twice weekly (e.g., Monday/Thursday) 60% report improved recovery, reduced joint pain, faster healing of chronic injuries Aligns with TB-500's half-life and angiogenic mechanism. Adequate tissue exposure Maintenanc
This comparison does not assign a generated winner or score.
- Loading Phase (4 weeks)
- 2–2.5mg per injection
- Twice weekly (e.g., Monday/Thursday)
- 60% report improved recovery, reduced joint pain, faster healing of chronic injuries
- Aligns with TB-500's half-life and angiogenic mechanism. Adequate tissue exposure
- Maintenance Phase
- 2mg per injection
- Once weekly
- Sustained benefits in flexibility and recovery reported by 40–50% of users
- Lower frequency maintains baseline angiogenic stimulus without oversaturation
- High-Dose Protocol
- 5mg per injection
- Twice weekly
- Mixed results. Some report accelerated healing, others report no additional benefit vs standard dose
- Exceeds therapeutic threshold documented in animal models. Unlikely to improve outcomes
- Daily Microdosing
- 0.5–1mg per injection
- Daily
- Minimal reported benefit. Most users abandon after 2–3 weeks
- Inefficient. Tissue concentrations remain elevated for 5–7 days, making daily dosing redundant
- Single Loading Dose
- 10mg total over 3 days
- Front-loaded, then stopped
- Poor long-term outcomes. Initial reduction in pain followed by return to baseline
- Insufficient duration for angiogenesis completion. New capillaries require 3–4 weeks to stabilise